Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_assertion type Assertion NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_head.
- NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_assertion description "[The amplification rate of C-myc, C-N-ras, C-Ki-ras and C-erbB-2 in ovarian carcinoma were 50%, 44%, 31% and 25% respectively.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_provenance.
- NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_assertion evidence source_evidence_literature NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_provenance.
- NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_assertion SIO_000772 8585978 NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_provenance.
- NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_assertion wasDerivedFrom befree-20140225 NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_provenance.
- NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_assertion wasGeneratedBy ECO_0000203 NP363632.RACS5RHV_NtBOGEtBxK9GhOSHH75tUUBmsWzp7BSRxZuQ130_provenance.